The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
about
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige miceMycobacterium avium strains resistant to clarithromycin and azithromycinComparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitisMICs and MBCs of clarithromycin against Mycobacterium avium within human macrophagesNovel microwell assay with high throughput and minimum consumption for organic solvents in the charge transfer-based spectrophotometric determination of clarithromycin in pharmaceutical formulationsThe new macrolides. Azithromycin and clarithromycin.Pharmacokinetics of azithromycin in pediatric patients with acute otitis mediaIncidence and cost of hospital admissions secondary to drug interactions involving theophylline.Impact of interconception antibiotics on the endometrial microbial flora.Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension.Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin.Current use of anti-infectives in dermatology.Azithromycin (zithromax).Pharmacokinetic properties of clarithromycin: A comparison with erythromycin and azithromycin.Controversies in the management of Mycobacterium avium complex infection in AIDS patients.The macrolide antibiotic renaissance.Reconstruction of the Saccharopolyspora erythraea genome-scale model and its use for enhancing erythromycin production.Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.Interactions of dirithromycin with human polymorphonuclear leukocytesDirithromycin: a new macrolide.Accumulation of clarithromycin in macrophages infected with Mycobacterium avium.Why use erythromycin?Resistance patterns of Haemophilus influenzae.Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers.PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin.Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B.Taste masking of azithromycin by resin complex and sustained release through interpenetrating polymer network with functionalized biopolymers.Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report.
P2860
Q28369131-0A3E3604-7588-4FBD-8383-8952FCAD94ACQ28369301-6B48D7FC-0FB3-47AD-88E1-7F6C469D7186Q28375792-B0DDBDB3-CCCD-48D0-8E79-C6A87A1DBF12Q28378654-500CA6F5-7CEB-46C8-89E9-EC44B87EF910Q28390567-FF197EF3-9D01-491E-97A3-4627BB9FB524Q33607251-A97A0A7E-748F-408C-AFA0-147A9F761F25Q35117726-AC4166F2-19A6-4757-974D-22096D757E57Q35657180-A6163026-3844-4232-BF20-1F8631C7D52AQ35762317-EFC6D36C-AD31-4969-9F02-860CA65DB37FQ35808966-F79586A8-1156-460B-8AC0-20CCD128E774Q35816447-3D8CE4F4-00CF-47DC-A175-C9B123912F2AQ36233506-86B5E61C-8306-4F7A-8244-F183B2113F1BQ36625096-F51F5BC1-8A86-43CB-8DAE-E80E1993660BQ37985906-5F03011A-157E-4B02-BC66-0944D73190D4Q38566706-D8903FA6-2454-4DF5-9B78-BA51AA18E24DQ39406507-AD78CBA9-489F-475E-BD20-9EDE8F05FFC4Q39577241-1ADC5174-E2B6-446D-B544-FE85FEAA2196Q39831380-DB344C05-37CE-471E-96B0-F323E675E26DQ39883640-50CD85CB-5E40-4200-947E-3F80D2394D7EQ40925660-82811D5A-901D-43CD-9037-C17A048E2E4AQ41499115-9CCA0331-4FE6-4856-9161-81D04727EC83Q42415391-48D8E17E-8766-4AC2-81AC-9BA69696EEA8Q43498288-BAD151E2-7EE4-4A91-88C4-20DE3CB70FBAQ43824923-E176D99C-EDDA-4D48-A219-1DC9845E6813Q44401287-BA4F7654-7FDF-4DA0-936F-388D493DF2DDQ47421964-E31E6B69-1A2F-4512-937B-77DE19149518Q47618040-407E588B-5CE3-4CFA-9B1F-7F18C9C99D97Q52936245-80062462-0DCC-444B-9424-9472E8F59AC3Q55188922-02E92DA2-B120-4B85-A596-E7267B6CEC39
P2860
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@ast
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@en
type
label
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@ast
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@en
prefLabel
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@ast
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@en
P2860
P1476
The new macrolide antibiotics: ...... ithromycin, and roxithromycin.
@en
P2093
P2860
P356
10.1177/106002809202600112
P407
P577
1992-01-01T00:00:00Z